PAPAP for COVID-19
PAPAP has been reported as potentially beneficial for
treatment of COVID-19. We have not reviewed these studies.
See all other treatments.
, In Silico #Favipiravir Isostere a Promising Remedy: Lead discovery for Covid-19 remedy. Laila A Abou-Zeid; Associate Professor. FOP, Delta University & Mansoura University, Center for Open Science, doi:10.31219/osf.io/myw67
<p>A newly emerged Human Coronavirus (HCoV) is reported three months ago in Wuhan, China (COVID-19). Based on the World Health Organization (WHO) reports until today more than 4000 deaths from the 114,000 confirmed cases reported. The current study aims to shed light on one of the promising lead against COVID-19.P-Amino-Antineoplastone small molecule that therapeutically evaluated as anticancer is evaluated for its complementarity and recognition at the binding site of the NSP15 endoribonuclease protein that just issued at 3rd of March 2020; at the protein data bank coded 6VWW.Based on the presence of common structural features in both pAPAP and the antiviral drug (Favilavir) that announced as the first line for treatment of positively tested coronavirus patients in China. In silico molecular docking of p-amino-phenylacetyl pipredinedione (pAPAP) in complex with NSP15 showed promising binding affinity that gives great anticipation inhibiting the endoribonuclease COVID19.</p>
Please send us corrections, updates, or comments.
c19early involves the extraction of 100,000+ datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Treatments and other interventions are complementary.
All practical, effective, and safe
means should be used based on risk/benefit analysis.
No treatment or intervention is 100% available and effective for all current
and future variants.
We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.